Medi Caps Ltd (MEDICAPQ) is currently trading at 25.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Medi-Caps Limited is a formerly leading empty hard gelatin capsule manufacturer that permanently discontinued manufacturing in 2019 and has repositioned itself into real estate development, operating a reportable Real Estate segment centered on the Medi-Caps Business Park while retaining legacy pharma assets and a wholly-owned subsidiary, Medgel Private Limited. The company reported consolidated total income of approximately INR 1,492.26 lakhs for H1 FY2026, while consolidated profit before tax for the same period was a loss of INR 531.32 lakhs, reflecting a volatile quarter mix where Q2 standalone and consolidated performance diverged and one-off real estate sales impacted revenue recognition. Standalone results show immediate monetization from real estate: the company booked standalone net sales of INR 99.78 lakhs in the quarter from shop sales at Medi-Caps Business Park, while standalone closing cash on the balance sheet is very low at INR 0.43 lakhs, highlighting near-term liquidity constraints on the standalone entity. The consolidated balance sheet carries significant non‑operating assets and goodwill (goodwill of INR 2,814.15 lakhs and other equity of INR 10,414.16 lakhs), while the consolidated cash flow for H1 FY2026 was negative on operating activities and overall led to a decrease in consolidated cash, underscoring a transitionary capital and liquidity profile.

Over the past 52 weeks, Medi Caps Ltd has traded between a low of ₹21.00 and a high of ₹44.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Medi Caps Ltd has a market capitalization of approximately 31.18. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Medi Caps Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -17.52 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 31.18 Cr, Medi Caps Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Medi Caps Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Medi Caps Ltd is -17.52. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.